Variant Philadelphia Chromosome t (2;9;22) (q21; q34; q11.2) in Chronic Myeloid Leukemia -Integrated Cytogenetic Analysis and Review
Journal of Clinical and Laboratory Research · 26.05.2026 · 09 (02) · 01-07
DOI: 10.31579/2768-0487/207 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical and Laboratory Research, online erschienen am 26.05.2026. Verfasst von Pina J Trivedi * und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Chronic Myeloid Leukemia (CML) is defined by the reciprocal translocation t (9;22) (q34; q11.2), which produces the BCR-ABL fusion oncogene. Rare variant translocations involving additional chromosomes such as t (2;9;22) (q21; q34; q11.2) add complexity to diagnosis and management. We report a 53-year-old male with CML in chronic phase harboring this rare variant, confirmed through conventional GTG-banded karyotyping and fluorescence in situ hybridization (FISH). Clinical presentation, laboratory findings and detailed cytogenetic analysis are discussed with reference to current literature.
Zitieren
APA
*, P. J. T., Barad, K., Patel, N., & Oza, R. (2026). Variant Philadelphia Chromosome t (2;9;22) (q21; q34; q11.2) in Chronic Myeloid Leukemia -Integrated Cytogenetic Analysis and Review. Journal of Clinical and Laboratory Research, 09(02), 01-07. https://doi.org/10.31579/2768-0487/207
Vancouver
* PJT, Barad K, Patel N, Oza R. Variant Philadelphia Chromosome t (2;9;22) (q21; q34; q11.2) in Chronic Myeloid Leukemia -Integrated Cytogenetic Analysis and Review. Journal of Clinical and Laboratory Research. 2026;09(02):01-07. doi:10.31579/2768-0487/207
BibTeX
@article{2026,
author = {*, Pina J Trivedi and Barad, Krishna and Patel, Nidhi and Oza, Rashmi},
title = {Variant Philadelphia Chromosome t (2;9;22) (q21; q34; q11.2) in Chronic Myeloid Leukemia -Integrated Cytogenetic Analysis and Review},
journal = {Journal of Clinical and Laboratory Research},
year = {2026},
volume = {09},
number = {02},
pages = {01--07},
doi = {10.31579/2768-0487/207}
}
EUVIMED